Treatment Modification to Reduce Symptom Burden in Hemodialysis
| Status: | Completed |
|---|---|
| Conditions: | Renal Impairment / Chronic Kidney Disease |
| Therapuetic Areas: | Nephrology / Urology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 10/10/2018 |
| Start Date: | January 2013 |
| End Date: | September 2014 |
Treatment Modification and Symptom Burden in High-Risk Dialysis Patients
Many patients on hemodialysis experience high rates of symptom burden, such as pain,
depression, anxiety and difficulty breathing. This study seeks to reduce these symptoms by
modifying the usual guidelines used to manage patients on hemodialysis. For example, rather
than trying to keep serum phosphorus below 5.5, patients enrolled in this study may have
treatment goals of less than 6.5, in order to reduce the number of pills they need to take
and potentially reduce harmful side effects. Blood pressure and serum parathyroid hormone
goals will also be modified, to see if these modifications help hemodialysis patients feel
better.
depression, anxiety and difficulty breathing. This study seeks to reduce these symptoms by
modifying the usual guidelines used to manage patients on hemodialysis. For example, rather
than trying to keep serum phosphorus below 5.5, patients enrolled in this study may have
treatment goals of less than 6.5, in order to reduce the number of pills they need to take
and potentially reduce harmful side effects. Blood pressure and serum parathyroid hormone
goals will also be modified, to see if these modifications help hemodialysis patients feel
better.
Inclusion Criteria:
- hemodialysis patient
- transplant ineligible
Exclusion Criteria:
- dementia
- unable to answer questionnaires for any reason
We found this trial at
1
site
Click here to add this to my saved trials
